Viewing Study NCT07299292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-02 @ 12:21 AM
Study NCT ID: NCT07299292
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-12-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Sponsor: SMED Clinical Research
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer (Diagnosis) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None castration View
None abiraterone View
None hormonal intensification View